1. Home
  2. SLP vs HYI Comparison

SLP vs HYI Comparison

Compare SLP & HYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLP
  • HYI
  • Stock Information
  • Founded
  • SLP 1996
  • HYI 2010
  • Country
  • SLP United States
  • HYI United States
  • Employees
  • SLP N/A
  • HYI N/A
  • Industry
  • SLP EDP Services
  • HYI Investment Managers
  • Sector
  • SLP Technology
  • HYI Finance
  • Exchange
  • SLP Nasdaq
  • HYI Nasdaq
  • Market Cap
  • SLP 322.4M
  • HYI 272.7M
  • IPO Year
  • SLP 1997
  • HYI N/A
  • Fundamental
  • Price
  • SLP $17.38
  • HYI $11.28
  • Analyst Decision
  • SLP Buy
  • HYI
  • Analyst Count
  • SLP 8
  • HYI 0
  • Target Price
  • SLP $26.80
  • HYI N/A
  • AVG Volume (30 Days)
  • SLP 418.1K
  • HYI 50.6K
  • Earning Date
  • SLP 12-01-2025
  • HYI 01-01-0001
  • Dividend Yield
  • SLP N/A
  • HYI 9.59%
  • EPS Growth
  • SLP N/A
  • HYI N/A
  • EPS
  • SLP N/A
  • HYI N/A
  • Revenue
  • SLP $80,383,000.00
  • HYI N/A
  • Revenue This Year
  • SLP $13.67
  • HYI N/A
  • Revenue Next Year
  • SLP $1.50
  • HYI N/A
  • P/E Ratio
  • SLP N/A
  • HYI N/A
  • Revenue Growth
  • SLP 20.01
  • HYI N/A
  • 52 Week Low
  • SLP $12.39
  • HYI $10.99
  • 52 Week High
  • SLP $37.67
  • HYI $12.24
  • Technical
  • Relative Strength Index (RSI)
  • SLP 54.59
  • HYI 31.28
  • Support Level
  • SLP $16.97
  • HYI $11.28
  • Resistance Level
  • SLP $17.80
  • HYI $11.39
  • Average True Range (ATR)
  • SLP 0.76
  • HYI 0.07
  • MACD
  • SLP -0.09
  • HYI 0.00
  • Stochastic Oscillator
  • SLP 35.04
  • HYI 0.00

About SLP Simulations Plus Inc.

Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.

About HYI Western Asset High Yield Defined Opportunity Fund Inc.

Western Asset High Yield Defined Opps. is a non-diversified, limited-term, closed-end management investment company. The company's investment objective is to provide high income and seek capital appreciation. The fund invests a majority of its net assets in a portfolio of high-yield corporate fixed-income securities issued or originated by U.S. or foreign public or private corporations and other business entities, with varying maturities.

Share on Social Networks: